Início › Leucemia Mieloide Aguda › Michigan › Ann Arbor
Ensaios clínicos de Leucemia Mieloide Aguda em Ann Arbor, MI
17 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Ann Arbor e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- e mais 4
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi de distância
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RecrutandoFase 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · a 7 mi de distância
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- e mais 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
RecrutandoFase 1
- C S Mott Children's Hospital, Ann Arbor
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi de distância
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · a 18 mi de distância
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi de distância
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · a 15 mi de distância
- e mais 1
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecrutandoFase 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
RecrutandoFase 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RecrutandoFase 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecrutandoFase 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
RecrutandoFase 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecrutandoFase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Ensaios de Leucemia Mieloide Aguda em outras cidades
- Houston, TX85 estudos
- New York City, NY51 estudos
- Boston, MA44 estudos
- Baldwin Park, CA40 estudos
- Seattle, WA40 estudos
- Columbus, OH35 estudos
- Philadelphia, PA34 estudos
- Durham, NC33 estudos
- Atlanta, GA30 estudos
- Tampa, FL29 estudos
- Chicago, IL26 estudos
- Portland, OR25 estudos
Outros estudos em Ann Arbor
- Câncer de Próstata27 estudos
- Câncer de Mama26 estudos
- Câncer de Pulmão de Não Pequenas Células26 estudos
- Câncer (todos os tipos)25 estudos
- Câncer Colorretal23 estudos
- Câncer de Pulmão23 estudos
- Insuficiência Cardíaca22 estudos
- Doença Cardiovascular16 estudos
- Câncer de Pâncreas14 estudos
- Melanoma12 estudos
- Câncer de Rim (Carcinoma de Células Renais)12 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço12 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.